Company Filing History:
Years Active: 2025
Title: Aya FadlAllah Abdelmonem Mohamed: A Pioneer in Cancer Treatment Innovations
Introduction
Aya FadlAllah Abdelmonem Mohamed is an innovative inventor based in Beni Suef, Egypt. She has contributed significantly to the field of cancer treatment through her groundbreaking research and patent in nanotechnology. Her work aims to provide effective solutions for tackling cancer, reflecting her dedication to advancing medical science.
Latest Patents
Among her notable achievements is her patent for a cancer treatment method utilizing aluminum silicate nanorods (SNRs). This patent describes a method of cytotoxically treating cancer by contacting SNRs at a concentration of 0.5 to 2 μg/mL with a cancerous sample. The SNRs, which range in size from 100 nanometers to 5500 nanometers in their longest dimension and have a diameter of 20 nanometers to 250 nanometers, are engineered to enhance their efficacy. The porous nature of these nanorods, with pore sizes of 1 nm to 12 nm, incorporates cisplatin in amounts from 20 to 300 mg/g, resulting in a notable reduction in cell viability of the cancerous samples upon treatment.
Career Highlights
Aya is currently affiliated with Imam Mohammad Ibn Saud Islamic University, where she conducts her research and develops her innovative treatment methods. Her work demonstrates a strong commitment to scientific inquiry and practical applications that could potentially improve cancer therapies.
Collaborations
Throughout her career, Aya has collaborated with esteemed colleagues such as Hassan Ahmed Rudayni and Ahmed Aly Allam. These partnerships highlight her ability to work within a team-oriented environment, fostering a spirit of collective innovation and advancement in the field of cancer research.
Conclusion
Aya FadlAllah Abdelmonem Mohamed stands out as a dynamic inventor in the realm of cancer treatment. Her pioneering work with aluminum silicate nanorods not only showcases her creativity and technical skills but also underscores the importance of innovative approaches in addressing global health challenges. As she continues to develop her research, her contributions may pave the way for new therapeutic strategies in the fight against cancer.